本研究目的在于测定肝硬化患者中充血性胃病(congestive gastropathy,CG)的患病率和发病率,及其与硬化剂治疗的关系、CG患者中幽门螺旋菌(HP)的检出率以及CG的自然过程。作者将1981～1986年经胃镜检查的212例肝硬化患者分为两组。(1)组:以往无上消化道出血史,137例;(2)组:有出血史并已开始用硬化剂治疗75例。平均随访时间46月。 CG的发生率在刚入院时27％,随访结束时为60％ The purpose of this study was to determine the prevalence and incidence of congestive gastropathy (CG) in cirrhotic patients and its relationship with sclerotherapy, the prevalence of Helicobacter pylori (HP) in CG patients and the prevalence of CG The natural process. The authors divided 212 patients with liver cirrhosis who underwent gastroscopy from 1981 to 1986 into two groups. (1) group: the history of upper gastrointestinal bleeding in the past, 137 cases; (2) group: a history of bleeding and has begun to use sclerosant treatment of 75 cases. The average follow-up time was 46 months. The incidence of CG was 27% at admission and 60% at the end of follow-up